UK-listed Ark Therapeutics Plc has reported revenue of £0.4 million for the first half of 2011, unchanged from a year as it shifted its business strategy to bio-manufacturing and early-stage research and sold its wound-care business. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
